Enlivex Therapeutics Ltd.

NasdaqCM:ENLV Stock Report

Market Cap: US$24.6m

Enlivex Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ENLV?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,098,9914.65%
Institutions1,597,4316.75%
Hedge Funds2,208,0009.34%
General Public18,746,56779.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 26.8%.

Top Shareholders

Top 25 shareholders own 20.64% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.34%
Armistice Capital LLC
2,208,000US$2.3m1.48%0.06%
3.63%
Shai Novik
858,775US$892.0k11%no data
2.68%
Millennium Management LLC
633,847US$658.4k0%no data
1.14%
Morgan Stanley, Investment Banking and Brokerage Investments
269,655US$280.1k9.73%no data
0.77%
Abraham Havron
181,459US$188.5k0.13%no data
0.67%
Renaissance Technologies LLC
158,992US$165.1k113%no data
0.58%
Meitav Investment House Ltd
137,319US$142.6k0.06%no data
0.47%
Phoenix Investments & Finances Ltd
110,763US$115.0k0%no data
0.22%
Ayalon Mutual Funds Ltd.
50,897US$52.9k0%no data
0.21%
Migdal Mutual Funds Ltd.
49,261US$51.2k-3.49%no data
0.18%
Oren Hershkovitz
42,046US$43.7k64.9%no data
0.12%
Sigma Investment Counselors, Inc.
28,000US$29.1k0%no data
0.095%
Two Sigma Securities, LLC, Asset Management Arm
22,362US$23.2k0%no data
0.074%
Virtu Financial LLC, Asset Management Arm
17,451US$18.1k0%no data
0.071%
Hudson River Trading LLC, Asset Management Arm
16,878US$17.5k0%no data
0.059%
Neuberger Berman Investment Advisers LLC
14,000US$14.5k0%no data
0.057%
Psagot Index Funds Ltd
13,385US$13.9k0%no data
0.054%
Jane Street Group, LLC, Asset Management Arm
12,873US$13.4k0%no data
0.047%
Susquehanna International Group, LLP, Asset Management Arm
11,159US$11.6k0%no data
0.044%
Geode Capital Management, LLC
10,420US$10.8k0%no data
0.039%
Wells Fargo & Company, Securities and Brokerage Investments
9,184US$9.5k0%no data
0.037%
I.B.I Mutual Funds Management (1978) Ltd.
8,750US$9.1k0%no data
0.024%
Osaic Wealth, Inc. , Asset Management Arm
5,737US$6.0k709%no data
0.023%
Shachar Shlosberger
5,475US$5.7k192%no data
0.022%
Einat Galamidi
5,321US$5.5k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/16 01:13
End of Day Share Price 2025/05/16 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Enlivex Therapeutics Ltd. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason KolbertD. Boral Capital LLC.
Raghuram SelvarajuH.C. Wainwright & Co.